The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huseby, E. S.
Right arrow Articles by Goverman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huseby, E. S.
Right arrow Articles by Goverman, J.
The Journal of Immunology, 1999, 163: 1115-1118.
Copyright © 1999 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Myelin Basic Protein-Specific Cytotoxic T Cell Tolerance Is Maintained In Vivo by a Single Dominant Epitope in H-2k Mice1

Eric S. Huseby*, Claes Öhlén* and Joan Goverman2,*,{dagger}

* Departments of Immunology and {dagger} Molecular Biotechnology, University of Washington, Seattle, WA 98195

Multiple sclerosis (MS) is believed to be an autoimmune disease mediated by T cells specific for CNS Ags. MS lesions contain both CD4+ and CD8+ T lymphocytes. The contribution of CD4+ T cells to CNS autoimmune disease has been extensively studied in an animal model of MS, experimental autoimmune encephalomyelitis. However, little is known about the role of autoreactive CD8+ cytotoxic T cells in MS or experimental autoimmune encephalomyelitis. We demonstrate here that myelin basic protein (MBP) is processed in vivo by the MHC class I pathway leading to a MBP79–87/Kk complex. The recognition of this complex by MBP-specific cytotoxic T cells leads to a high degree of tolerance in vivo. This study is the first to show that the pool of self-reactive lymphocytes specific for MBP contain MHC class I-restricted T cells whose response is regulated in vivo by the induction of tolerance.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
Q. JI and J. GOVERMAN
Experimental Autoimmune Encephalomyelitis Mediated by CD8+ T Cells
Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 157 - 166.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Tsunoda, L.-Q. Kuang, M. Kobayashi-Warren, and R. S. Fujinami
Central Nervous System Pathology Caused by Autoreactive CD8+ T-Cell Clones following Virus Infection
J. Virol., December 1, 2005; 79(23): 14640 - 14646.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. A. Friese and L. Fugger
Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Brain, August 1, 2005; 128(8): 1747 - 1763.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
E. S. Huseby, D. Liggitt, T. Brabb, B. Schnabel, C. Ohlen, and J. Goverman
A Pathogenic Role for Myelin-specific CD8+ T Cells in a Model for Multiple Sclerosis
J. Exp. Med., September 4, 2001; 194(5): 669 - 676.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
E. S. Huseby and J. Goverman
Tolerating the Nervous System: A Delicate Balance
J. Exp. Med., February 28, 2000; 191(5): 757 - 760.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.